Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1208P (RNA, U6 small nuclear 1208, pseudogene) is a non-coding RNA pseudogene, annotated in human and other genomes as a member of the U6 small nuclear RNA pseudogene family[4][5]. It does not produce a functional RNA or protein, and does not play an active role in cellular processes. The canonical U6 small nuclear RNAs are essential components of the spliceosome, the major RNA-protein complex responsible for catalyzing pre-mRNA splicing in eukaryotes[1][3]. However, pseudogenes such as RNU6-1208P are non-functional copies or gene fragments that generally lack regulatory elements, are not transcribed into stable RNAs, and do not contribute to spliceosomal activity. Thus, RNU6-1208P is not considered a receptor, enzyme, or other therapeutic target, and there is no evidence for pharmacological, diagnostic, or disease relevance[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1208, pseudogene (RNU6-1208P).